Edgewise Therapeutics (NASDAQ:EWTX) just reported results for the first quarter of 2024.
- Edgewise Therapeutics reported earnings per share of -33 cents. This was above the analyst estimate for EPS of -39 cents.
- The company did not report any revenue for the quarter.